CNS Pharmaceuticals, Inc. Common Stock (CNSP) is a publicly traded Healthcare sector company. As of August 12, 2026, CNSP trades at $5.25 with a market cap of $7.50M and a P/E ratio of -0.15. CNSP moved +0.00% today. Year to date, CNSP is +4.76%; over the trailing twelve months it is -17.05%. Its 52-week range spans $1.90 to $114.00. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces CNSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CNSP, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $5.25 |
| Market Cap | $7.50M |
| P/E Ratio | -0.15 |
| EPS | $-35.75 |
| Dividend Yield | 0.00% |
| 52-Week High | $114.00 |
| 52-Week Low | $1.90 |
| Volume | 2.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-15.85M |
| Gross Margin | 0.00% |
1 analysts cover CNSP: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.